Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson is an American company founded in 1886. It is one of the world's largest manufacturers of pharmaceuticals, medical equipment, hygiene, health and cosmetic products and also provides related services to consumers as well as healthcare professionals.

Johnson & Johnson currently offers a dividend of over 3.4%, slightly higher than its long-term average of 3.09%. In the medium term, the company has managed to increase its distributions at an annual rate of 9.14%. Above all, it has achieved the feat ofincreasing its dividend every year for 48 years, which gives a good idea of the ability of Johnson & Johnson to weather crises.

The payout rate is attractive, at 43.33%, which leaves Johnson & Johnson with a good margin in case of a difficult transition.  The volatility is 7.18%, the lowest of the titles in our portfolio.. With such figures, we are closer to the risk of bonds than that of shares...

For several months, Johnson & Johnson is overlooked by the market, which means it is trading at very attractive prices, both in terms of dividends and profits. Over the longer term, however, the company has clearly beaten the market.

Our algorithm considers JNJ to be a purchase opportunity to this day.